Intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in children. Do they play a role in the progression of atherosclerosis?

Hormones

Volumn 11, Issue 2, 2012, Pages 140-146

  Fotis, Lampros ^a   Giannakopoulos, Dionysios ^b   Stamogiannou, Lela ^a   Xatzipsalti, Maria ^a  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b Private Veterinary Practitioner   (Greece)

Author keywords

Atherosclerosis; Cell adhesion molecules; Childhood obesity; Diabetes mellitus; Hypercholesterolemia; Intercellular adhesion molecule 1; Type 1; Vascular cell adhesion molecule 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHILD; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILIAL HYPERCHOLESTEROLEMIA; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; OBESITY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW;

EID: 84863494551     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1340     Document Type: Review

References (65)

1. Barker DJ, 1995 Fetal origins of coronary heart disease. BMJ 311:171-174.
2. Seidman DS, Laor A, Gale R, Stevenson DK, Danon YL, 1991 A longitudinal study of birth weight and being overweight in late adolescence. Am J Dis Child 145: 782-785.
3. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ, 2001 Early growth and coronary heart disease in later life: longitudinal study. Br Med J 322: 949-953.
4. Libby P, 2000 Changing concepts of atherogenesis. J Intern Med 247: 349-358.
5. Price DT, Loscalzo J, 1999 Cellular adhesion molecules and atherogenesis. Am J Med, 107: 85-97.
6. Ramos KS, Partridge CR, Teneng I, 2007 Genetic and molecular mechanisms of chemical atherogenesis. Mutat Res 62: 18-30.
7. van de Stolpe A, van der Saag PT, 1996 Intercellular adhesion molecule-1. J Mol Med (Berlin, Germany) 74: 13-33.
8. Hubbard AK, Rothlein R, 2000 Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28:1379-1386.
9. van Buul JD, Kanters E, Hordijk PL, 2007 Endothelial signaling by Ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol 27: 1870-1876.
10. Witkowska AM, Borawska MH, 2004 Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw 15: 91-98.
11. Elangbam CS, Qualls CW, Jr., Dahlgren RR, 1997 Cell adhesion molecules-update. Vet Pathol 34: 61-73.
12. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH, 1998 Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 188: 465-474.
13. Carter RA, Wicks IP, 2001 Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum 44: 985-994.
14. Kelly KA, Allport JR, Yu AM, et al, 2007 SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J Leukoc Biol 81: 748-756.
15. Postigo AA, Teixido J, Sanchez-Madrid F, 1993 The alpha 4 beta 1/VCAM-1 adhesion pathway in physiology and disease. Res Immunol 144: 723-735; discussion 754-762.
16. Leca G, Mansur SE, Bensussan A, 1995 Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol 154: 1069-1077.
17. Phocas I, Sarandakou A, Giannaki G, Malamitsi-Puchner A, Rizos D, Zourlas PA, 1998 Soluble intercellular adhesion molecule-1 in newborn infants. Eur J Pediatr 157: 153-156.
18. Malamitsi-Puchner A, Tziotis J, Mastorakos G, Protonotariou E, Creatsas G, 2000 Adhesion molecules in early neonatal life. Biol Neonate 78: 65-67.
19. Nash MC, Wade AM, Shah V, Dillon MJ, 1996 Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 103: 167-170.
20. Ohta T, Saku K, Takata K, Adachi N, 1999 Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children. Eur J Pediatr 158: 592-598.
21. Ponthieux A, Herbeth B, Droesch S, Haddy N, Lambert D, Visvikis S, 2004 Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 172: 299-308.
22. Al-Isa AN, Thalib L, Akanji AO, 2010 Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 208: 543-549.
23. Sack U, Burkhardt U, Borte M, Schadlich H, Berg K, Emmrich F, 1998 Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 5: 28-32.
24. Toivonen A, Kulmala P, Rahko J, Ilonen J, Knip M, 2004 Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes. Diabetes Metab Res Rev 20: 48-54.
25. Chen Y, Osika W, Dangardt F, Gan LM, Strandvik B, Friberg P, High levels of soluble intercellular adhesion molecule-1, insulin resistance and saturated fatty acids are associated with endothelial dysfunction in healthy adolescents. Atherosclerosis 211: 638-642.
26. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG, 2005 C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112:976-983.
27. Pradhan AD, Rifai N, Ridker PM, 2002 Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 106: 820-825.
28. Wojakowski W, Gminski J, 2001 Soluble ICAM-1, VCAM-1 and E-selectin in children from families with high risk of atherosclerosis. Int J Mol Med 7: 181-185.
29. McEleavy OD, McCallum RW, Petrie JR, et al, 2004 Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabet Med 21: 262-266.
30. Charakida M, Tousoulis D, Skoumas I, et al, 2009 Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Atherosclerosis 204: 532-537.
31. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J, 1998 Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351: 88-92.
32. Hwang SJ, Ballantyne CM, Sharrett AR, et al, 1997 Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96: 4219-4225.
33. de Lemos JA, Hennekens CH, Ridker PM, 2000 Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 36: 423-426. 34.
34. Zhu Y, Liao HL, Lin JH, Verna L, Stemerman MB, 1999 Low-density lipoprotein augments interleukin-1-induced vascular adhesion molecule expression in human endothelial cells. Atherosclerosis 144:357-365.
35. Malik I, Danesh J, Whincup P, et al, 2001 Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358: 971-976.
36. Benitez MB, Cuniberti L, Fornari MC, et al, 2008 Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia. Atherosclerosis 197: 679-687.
37. Kavazarakis E, Moustaki M, Gourgiotis D, et al, 2002 The impact of serum lipid levels on circulating soluble adhesion molecules in childhood. Pediatr Res 52: 454-458.
38. Glowinska B, Urban M, Peczynska J, Florys B, 2005 Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54: 1020-1026.
39. Tounian P, Aggoun Y, Dubern B, et al, 2001 Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358: 1400-1404.
40. Desideri G, De Simone M, Iughetti L, et al, 2005 Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab 90: 3145-3152.
41. Suheyl Ezgu F, Hasanoglu A, Tumer L, Ozbay F, Aybay C, Gunduz M, 2005 Endothelial activation and inflammation in prepubertal obese Turkish children. Metabolism 54: 1384-1389.
42. Caballero AE, Bousquet-Santos K, Robles-Osorio L, et al, 2008 Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care 31: 576-582.
43. Fontana L, Giagulli C, Minuz P, Lechi A, Laudanna C, 2001 8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 21: 55-60.
44. Kapiotis S, Holzer G, Schaller G, et al, 2006 A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 26: 2541-2546.
45. Lee S, Gungor N, Bacha F, Arslanian S, 2007 Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care 30: 2091-2097.
46. Sinha R, Fisch G, Teague B, et al, 2002 Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346: 802-810.
47. Barja S, Arteaga A, Acosta AM, Hodgson MI, 2003 Insulin resistance and other expressions of metabolic syndrome in obese Chilean children. Rev Med Chil, 131: 259-268.
48. Lee S, Bacha F, Gungor N, Arslanian S, 2008 Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 152: 177-184.
49. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER, 1999 Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr 69: 381-387.
50. Martos R, Valle M, Morales RM, Canete R, Gascon F, Urbano MM, 2009 Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism 58: 1153-1160.
51. Valle Jimenez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, Guitarte FB, 2007 Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 156: 497-502.
52. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M, 2005 Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett 26:473-479.
53. Beauloye V, Zech F, Tran HT, Clapuyt P, Maes M, Brichard SM, 2007 Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 92: 3025-3032.
54. Goonasekera CD, Shah V, Rees DD, Dillon MJ, 2000 Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Blood Press 9: 16-21.
55. Hamdy O, Ledbury S, Mullooly C, et al, 2003 Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26: 2119-2125.
56. Hope SA, Meredith IT, 2003 Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J 33: 450-462.
57. Berry JD, Dyer A, Cai X, et al, 2012 Lifetime risks of cardiovascular disease. N Engl J Med 366:321-329.
58. Libby P, Nathan DM, Abraham K, et al, 2005 Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation 111: 3489-3493.
59. Seckin D, Ilhan N, Ilhan N, Ertugrul S, 2006 Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diabetes Res Clin Pract 73: 191-197.
60. Triolo G, Accardo-Palumbo A, Carbone MC, Ferrante A, Casiglia D, Giardina E, 1998 IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells. Clin Exp Immunol 111: 491-496.
61. Toivonen A, Kulmala P, Savola K, Akerblom HK, Knip M, 2001, The Childhood Diabetes In F: Soluble adhesion molecules in preclinical type 1 diabetes. The Childhood Diabetes in Finland Study Group. Pediatr Res 49: 24-29.
62. Keaney JF Jr, Massaro JM, Larson MG, et al, 2004 Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 44: 168-173.
63. Luc G, Arveiler D, Evans A, et al, 2003, Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 170: 169-176.
64. Rohde LE, Lee RT, Rivero J, et al, 1998 Circulating cell adhesion molecules are correlated with ultrasoundbased assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 18: 1765-1770.
65. De Caterina R, Basta G, Lazzerini G, et al, 1997 Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17: 2646-2654.